Success Metrics

Clinical Success Rate

100.0%

Based on 6 completed trials

Completion Rate

100%(6/6)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

17%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution1 total trials

N/ANon-phased studies

1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(6)

Detailed Status

Completed6

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

completed6100%

Recent Activity

0 active trials

Showing 5 of 6

completed

Effects of Chemotherapy on the Brain in Women With Newly Diagnosed Early-Stage Breast Cancer

NCT00755313

completed

Metabolic Syndrome in Young Patients With Acute Lymphoblastic Leukemia in Remission

NCT00801346

completed

Clinical Trials (6)

Showing 6 of 6 trials

NCT00755313

Effects of Chemotherapy on the Brain in Women With Newly Diagnosed Early-Stage Breast Cancer

Completed

NCT00801346

Metabolic Syndrome in Young Patients With Acute Lymphoblastic Leukemia in Remission

Completed

NCT01581528

Studying Samples From Patients With T-Cell Acute Lymphoblastic Leukemia

Completed

NCT00920738

Metabolic Syndrome in Childhood Cancer Survivors

Completed

NCT00258453Not Applicable

Observation of Young Patients Who Are Undergoing Surgery for Craniopharyngioma

Completed

NCT00897078

Study of Metabolic Syndrome in Young Patients Who Are Acute Lymphoblastic Leukemia Survivors and Their Healthy Siblings

Completed

All 6 trials loaded

Drug Details

Intervention Type: OTHER
Total Trials: 6